Novo Nordisk A/S ADR (NVO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | NVO | LLY | JNJ | ||
| Company | Novo Nordisk A/S ADR | Eli Lilly and Company | Johnson & Johnson | ||
| Price Information | |||||
| Exchange | NYSE | NYSE | NYSE | ||
| Open | 128.05 | 775.00 | 146.88 | ||
| High | 130.46 | 795.50 | 146.88 | ||
| Low | 127.49 | 767.66 | 144.53 | ||
| Last | 128.31 | 781.10 | 144.59 | ||
| Change | +1.43 | +43.90 | -2.23 | ||
| % Change | +1.13% | +5.95% | -1.52% | ||
| Volume | 7,841,000 | 7,437,100 | 8,817,700 | ||
| 20-Day Average Volume | 3,601,200 | 2,598,415 | 8,278,345 | ||
| Previous Close | 126.88 | 737.20 | 146.82 | ||
| Industry | Large Cap Pharma | Large Cap Pharma | Large Cap Pharma | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 125.46 | 752.12 | 148.58 | ||
| 20-Day Raw Stochastic | 75.17% | 81.35% | 9.79% | ||
| 20-Day Relative Strength | 55.39% | 58.69% | 33.47% | ||
| Weighted Alpha | +59.83 | +81.44 | -13.26 | ||
| Today's Opinion | 72% Buy | 80% Buy | 100% Sell | ||
| Previous Opinion | 72% Buy | 40% Buy | 100% Sell | ||
| Last Month's Opinion | 88% Buy | 88% Buy | 24% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -0.26% since 04/23/24 | +4.75% since 04/23/24 | -3.32% since 04/23/24 | ||
| Low | 123.21 on 04/25/24 | 718.30 on 04/25/24 | 144.53 on 04/30/24 | ||
| High | 130.46 on 04/30/24 | 795.50 on 04/30/24 | 149.58 on 04/25/24 | ||
| 1-Month | |||||
| %Chg | -0.07% since 03/28/24 | +0.40% since 03/28/24 | -8.60% since 03/28/24 | ||
| Low | 121.79 on 04/16/24 | 718.30 on 04/25/24 | 143.13 on 04/18/24 | ||
| High | 130.46 on 04/30/24 | 795.50 on 04/30/24 | 158.15 on 04/01/24 | ||
| 3-Month | |||||
| %Chg | +17.69% since 01/30/24 | +21.10% since 01/30/24 | -8.93% since 01/30/24 | ||
| Low | 112.15 on 01/31/24 | 637.00 on 01/31/24 | 143.13 on 04/18/24 | ||
| High | 138.28 on 03/07/24 | 800.78 on 03/04/24 | 163.11 on 03/12/24 | ||
| 6-Month | |||||
| %Chg | +33.10% since 10/30/23 | +38.07% since 10/30/23 | -1.66% since 10/30/23 | ||
| Low | 94.73 on 12/11/23 | 547.61 on 10/31/23 | 143.13 on 04/18/24 | ||
| High | 138.28 on 03/07/24 | 800.78 on 03/04/24 | 163.58 on 01/22/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 569,378,048 | 700,460,864 | 353,804,352 | ||
| Shares Outstanding, K | 4,487,532 | 950,164 | 2,409,783 | ||
| Annual Sales | 33,724,300,000 | 34,124,100,000 | 85,159,000,000 | ||
| Annual Net Income | 12,150,770,000 | 5,240,400,000 | 35,153,000,000 | ||
| Last Quarter Sales | 9,526,160,000 | 9,353,400,000 | 21,383,000,000 | ||
| Last Quarter Net Income | 3,175,360,000 | 2,189,700,000 | 5,354,000,000 | ||
| 60-Month Beta | 0.41 | 0.34 | 0.53 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 0.71 on 01/31/24 | 2.49 on 02/06/24 | 2.71 on 04/16/24 | ||
| Latest Earnings Date | 05/02/24 | 04/30/24 | 04/16/24 | ||
| Most Recent Dividend | 0.663 on 03/22/24 | 1.300 on 02/14/24 | 1.190 on 02/16/24 | ||
| Next Ex-Dividends Date | 03/22/24 | 02/14/24 | 05/20/24 | ||
| Ratios | |||||
| Price/Earnings ttm | 46.89 | 116.06 | 13.97 | ||